Video Courtesy of The NASH Education Program™
Click here for a brief synopsis. Video Courtesy of Pinnacle Clinical Research and AASLD TV
Fibrosis, not NASH, predicts death, disease in fatty liver
Date: 15 Aug 2017
Nonalcoholic steatohepatitis did not increase the risk for liver-related morbidity, overall mortality or the time to development of severe liver disease in patients with nonalcoholic fatty liver disease, according to recently published data. However, fibrosis stage can be used as a significant marker.
Read MoreNASH linked to early markers of hypertrophy
Date: 26 Jul 2017
Whether diastolic dysfunction similarly portends a risk of future [heart failure] among patients with NAFLD and/or NASH remains unknown, and we eagerly await well-designed, prospective studies to characterize this relationship.
Read MoreAASLD releases NAFLD practice guides for screening, treatmen...
Date: 19 Jul 2017
In contrast to the incidence data, there is a significantly higher number of publications describing the prevalence of NAFLD in the general population.
Read MoreMillions of people are living with a silent disease they've...
Date: 06 Jul 2017
NASH is set to surpass hepatitis as the biggest reason for liver transplants by 2020. That is seriously alarming!
Read MoreNASH: KOL Insight [2017]
Date: 05 Jul 2017
Key takeaway from experts on current study designs and endpoints, and the challenges facing novel therapies such as long-term safety, cost and diagnosis.
Read MoreFatty liver disease can be a silent killer
Date: 03 Jul 2017
Story by The New Paper, Singapore.
According to a report in Singapore's The New Paper (TNP), Non-alcoholic fatty liver disease - which can lead to liver cirrhosis or cancer - is on the rise in Singapore.
Read MoreAASLD Foundation announces $3.34 Million in liver disease re...
Date: 30 Jun 2017
Story by AASLD.
“Liver disease continues to be a critical healthcare issue in the United States and internationally. Despite recent strides and successes in the treatment of many liver diseases, AASLD Foundation understands there is still much work to be done and more funding must be made available to those interested in hepatology.” - Bruce R. Bacon, MD, FAASLD, AASLD Foundation Chair.
Read MoreLooking for clues for dangerous fatty liver disease
Date: 26 Jun 2017
"When you combine the fact that the natural history of the disease is unclear; it's difficulty to diagnose, treat and stage it; and there's no FDA-approved medicine, it becomes a huge issue." - Dr. Jaideep Behari, associate professor of medicine at the University of Pittsburgh and director of Fatty Liver Clinic.
Read MoreFirst-degree relatives of patients with NAFLD-cirrhosis at r...
Date: 19 Jun 2017
"According to researchers, first-degree relatives of patients with nonalcoholic fatty liver disease and cirrhosis have a 12-times higher risk for developing advanced fibrosis compared with first-degree relatives without NAFLD."
Read MoreNon-Alcoholic Fatty Liver Disease (NAFLD) Forecast in 11 Maj...
Date: 13 Jun 2017
Report by Research and Markets.
Research and Markets has announced the addition of the "Non-Alcoholic Fatty Liver Disease (NAFLD) Forecast in 11 Major Markets 2017-2027" report to their offering.
Read More